Rosetta Genomics Ltd (NASDAQ:ROSG)

Data as of 10:51am ET
 -0.06 / -1.92%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Rosetta Genomics Ltd. is seeking to develop and commercialize new diagnostic tests and therapeutics based on a group of genes known as microRNAs. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA and are believed to play an important role in normal function and in various pathologies. The company's cancer testing services are available through its Philadelphia-based CAP-accredited and CLIA-certified lab. Rosetta Genomics was founded in March 2000 by Bentwich Isaac and is headquartered in Rehovot, Israel.

Contact Information

Rosetta Genomics Ltd.
10 Plaut Street
Rehovot -- 76706
Investor Relations:



Other institutional3.99%
Mutual fund holders0.23%
Individual stakeholders--

Top Executives

Kenneth A. BerlinPresident, CEO & Head-Investor Relations
Ron KalfusChief Financial Officer
Eti MeiriVice President-Research
E. Robert WassmanChief Medical Officer
Dganit BarChief Scientific Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.